Evidence map›Paper›PMID 37624339›Full record

ArticleTropical medicine and infectious disease2023

Nanoformulation-Based 1,2,3-Triazole Sulfonamides for Anti-

Fadwa M Arafa, Heba Said, Doaa Osman, Nadjet Rezki, Mohamed R Aouad, Mohamed Hagar, Mervat Osman, Bassma H Elwakil, Mariusz Jaremko, Mona Mohamed Tolba

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Tropical medicine and infectious disease, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Fadwa M ArafaDepartment of Medical Parasitology, Faculty of Medicine, Alexandria University, Alexandria 21577, Egypt.ORCID 0000-0002-7753-3193
Heba SaidDepartment of Parasitology, Medical Research Institute, Alexandria University, Alexandria 21561, Egypt.ORCID 0000-0002-8092-2843
Doaa OsmanDepartment of Parasitology, Medical Research Institute, Alexandria University, Alexandria 21561, Egypt.
Nadjet RezkiDepartment of Chemistry, College of Science, Taibah University, Al Madinah Al Munawarah 30002, Saudi Arabia.
Mohamed R AouadDepartment of Chemistry, College of Science, Taibah University, Al Madinah Al Munawarah 30002, Saudi Arabia.
Mohamed HagarDepartment of Chemistry, Faculty of Science, Alexandria University, Alexandria 21321, Egypt.ORCID 0000-0003-0169-7738
Mervat OsmanDepartment of Parasitology, Medical Research Institute, Alexandria University, Alexandria 21561, Egypt.
Bassma H ElwakilDepartment of Medical Laboratory Technology, Faculty of Applied Health Sciences Technology, Pharos University in Alexandria, Alexandria 21526, Egypt.ORCID 0000-0001-6596-3156
Mariusz JaremkoSmart-Health Initiative (SHI) and Red Sea Research Center (RSRC), Division of Biological and Environmental Sciences and Engineering (BESE), King Abdullah University of Science and Technology (KAUST), Thuwal 23955, Saudi Arabia.
Mona Mohamed TolbaDepartment of Parasitology, Medical Research Institute, Alexandria University, Alexandria 21561, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

1,2,3-triazolechitosan nanoparticlesin vitro studiessulfonamidesToxoplasma gondii

Identifiers

PMID37624339
PMCPMC10460005

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.